Abstract

Basics of Compounding: Standardization of Compounded Medications

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2019 - Volume 23, Number 1

Page(s): 35-44

Download in electronic PDF format for $75

Abstract

The feasibility of standardizing concentrations of compounded drug preparations to attempt to minimize adverse events of both nonsterile and sterile compounded preparations has been discussed. It is critical that a wide variety of opinions and potential “unintended consequences” be aired in the public before an issue like this is recommended to become a standard. In this article, we combine the thoughts and recommendations of many practicing compounding pharmacists from both community and hospital practice sites that have contributed to this topic through the International Journal of Pharmaceutical Compounding’s Compounders’ Network List, a complimentary listserve for our subscribers to share information; ask questions; and provide answers, comments, and opinions. We discuss the advantages, disadvantages, and unintended consequences of standardized concentrations and provide input from numerous practitioners who are “on the front lines” daily.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2019 Pg. 35-44	Basics of Compounding: Standardization of Compounded Medications Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 222-229	Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 44-50	Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin
Sep/Oct 2021 Pg. 396-400	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 305-313	Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 131-139	Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 456-460	Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Author(s): Lyon Joanna
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Nov/Dec 2011 Pg. 526-527	PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Author(s): Williams LaVonn A
Mar/Apr 2023 Pg. 123-139	Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 358-364	Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Author(s): Palma Elisabetta, Bufarini Celestino
May/Jun 2016 Pg. 202-206	Does Your Drug Expertise Include Clinical Pharmaceutics? Author(s): Newton David W
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 358-362	Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Author(s): Cabaleiro Joe
Jul/Aug 2022 Pg. 298-301	The Role of Compounding Pharmacists During Drug Shortages Author(s): Ofei Kelvin
Sep/Oct 2014 Pg. 379-380	Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Author(s): Blankenship Cynthia E